Outset Medical Files Definitive Proxy Statement
Ticker: OM · Form: DEF 14A · Filed: Feb 4, 2025 · CIK: 1484612
| Field | Detail |
|---|---|
| Company | Outset Medical, INC. (OM) |
| Form Type | DEF 14A |
| Filed Date | Feb 4, 2025 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 19 min |
| Key Dollar Amounts | $0.001, $0.80, $125 million, $100 million, $200 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, corporate-governance
Related Tickers: OM
TL;DR
Outset Medical (OM) filed its proxy statement for the March 5th meeting. Shareholders vote soon.
AI Summary
Outset Medical, Inc. filed its definitive proxy statement (DEF 14A) on February 4, 2025, for its annual meeting on March 5, 2025. The filing provides information required for the proxy statement, including details for shareholders to vote on company matters. The company, previously known as Home Dialysis Plus, Ltd., is based in San Jose, CA.
Why It Matters
This filing is crucial for shareholders as it outlines the agenda for the upcoming annual meeting and provides the information needed to cast their votes on important company decisions.
Risk Assessment
Risk Level: low — A DEF 14A filing is a routine disclosure for public companies and does not inherently present new risks.
Key Numbers
- 001-39513 — SEC File Number (Identifies the company's filings with the SEC.)
- 3845 — SIC Code (Classifies the company's industry as Electromedical & Electrotherapeutic Apparatus.)
Key Players & Entities
- Outset Medical, Inc. (company) — Registrant
- Home Dialysis Plus, Ltd. (company) — Former company name
- 0001140361-25-003034.txt (document) — Filing document identifier
- 20250204 (date) — Filing date
- 20250305 (date) — Meeting date
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is used by companies to solicit proxies from shareholders for an upcoming shareholder meeting, providing essential information for voting.
When is the Outset Medical, Inc. annual meeting scheduled?
The annual meeting for Outset Medical, Inc. is scheduled for March 5, 2025.
What was Outset Medical, Inc.'s former name?
Outset Medical, Inc. was formerly known as Home Dialysis Plus, Ltd.
What is the filing date of this DEF 14A?
This definitive proxy statement was filed on February 4, 2025.
Where is Outset Medical, Inc. headquartered?
Outset Medical, Inc. is headquartered at 3052 Orchard Drive, San Jose, CA 95134.
Filing Stats: 4,847 words · 19 min read · ~16 pages · Grade level 11.7 · Accepted 2025-02-04 16:58:04
Key Financial Figures
- $0.001 — y's outstanding common stock, par value $0.001 per share (the " Common Stock ") upon t
- $0.80 — Common Stock at the conversion price of $0.80 per share subject to the terms and limi
- $125 million — saction, the Company also secured up to $125 million in new debt financing with a new lender
- $100 million — financing with a new lender, borrowing $100 million at closing which was used, along with c
- $200 million — used, along with cash on hand, to repay $200 million in prior debt. The Company believes tha
Filing Documents
- ny20040487x3_def14a.htm (DEF 14A) — 273KB
- ny20040487x3_pc01.jpg (GRAPHIC) — 793KB
- ny20040487x3_pc02.jpg (GRAPHIC) — 457KB
- 0001140361-25-003034.txt ( ) — 1994KB
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 23 ADDITIONAL INFORMATION 25 APPENDIX A A-1 i TABLE OF CONTENTS Outset Medical, Inc. 3052 Orchard Drive San Jose, California 95134 SPECIAL MEETING OF STOCKHOLDERS TO BE HELD ON MARCH 5, 2025 PROXY STATEMENT GENERAL INFORMATION This proxy statement is furnished to stockholders of Outset Medical, Inc., a Delaware corporation (the " Company ," " we ," " our " or " us "), in connection with the solicitation of proxies by our Board of Directors (our " Board ") for use at a special meeting of stockholders to be held on March 5, 2025, and at any adjournment or postponement thereof (the " Special Meeting "). The Special Meeting will be held at 8:30 a.m., Pacific Time, in a virtual format via live audio webcast. This proxy statement and the accompanying proxy card are first being made available to stockholders on or about February 4, 2025. We will hold the Special Meeting as a virtual meeting via live audio webcast. You will be able to attend the Special Meeting, vote your shares electronically and submit your questions online by visiting www.virtualshareholdermeeting.com/OM2025SM and entering the 16-digit control number included in your proxy card or the voting instructions that accompanied these proxy materials. We believe that conducting the Special Meeting as a virtual meeting will encourage higher levels of stockholder participation and facilitate active and equal participation for all stockholders at no cost regardless of geographic location. We have designed our virtual format to help ensure that our stockholders who attend the Special Meeting virtually will be afforded similar rights and opportunities to participate as they would at an in-person meeting. These materials are also available at https://investors.outsetmedical.com . Please note that information contained on our website does not constitute a part of, and is not incorporated by reference into, this proxy statement.